Brochure | April 25, 2022

BioReliance Viral Vector Manufacturing Capabilities

With more than 25 years’ experience manufacturing viral vectors for pre-clinical studies to commercialization and highly qualified experts invested in the process development, scale-up, tech transfer, and manufacturing of viral vectors we are the best strategic partner for you. We have process development/tech transfer/manufacturing teams with proven history of successful tech transfer and continuous process improvement. Our proven scalable platforms can overcome production challenges with Lentivirus and Adeno-Associated Virus (AAV). Our Project Management team is dedicated to keeping both manufacturing and development projects on time and our Product Development Process (PDP) ensures development of a risk-based and scalable processes designed to build solid foundation for commercialization. We have established synergy between production and testing within one company supporting early development through commercial production, proven FDA/EMA compliant quality systems for commercial release of approved products, and a history of successfully navigating the commercial regulatory pathways.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: